GCM2
Basic information
Region (hg38): 6:10873223-10882041
Previous symbols: [ "GCMB" ]
Links
Phenotypes
GenCC
Source:
- familial isolated hypoparathyroidism due to agenesis of parathyroid gland (Supportive), mode of inheritance: AR
- familial isolated hyperparathyroidism (Supportive), mode of inheritance: AD
- hyperparathyroidism 4 (Limited), mode of inheritance: Unknown
- hypoparathyroidism, familial isolated, 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypoparathyroidism, familial isolated, 2; Hyperparathyroidism 4 | AD/AR | Endocrine; Oncologic | In Hypoparathyroidism, familial isolated, early recognition of electrolyte abnormalitities (eg, hypocalcemia) can allow prompt treatment in order to avoid severe sequelae; In Hyperparathyroidism 4, individuals have been described with multiple parathyroid tumors (as well as other neoplasms), and awareness may allow early diagnosis and management of these tumors and sequelae | Endocrine; Oncologic | 15863676; 18583467; 19940031; 20190276; 20463099; 22066718; 23155703; 27745835 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Familial hypoparathyroidism (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GCM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 27 | ||||
missense | 41 | 10 | 61 | |||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 3 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 15 | 27 | 46 | |||
Total | 4 | 10 | 63 | 36 | 34 |
Highest pathogenic variant AF is 0.00000657
Variants in GCM2
This is a list of pathogenic ClinVar variants found in the GCM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-10873249-T-C | Familial hypoparathyroidism | Uncertain significance (Jan 12, 2018) | ||
6-10873268-G-GA | Familial hypoparathyroidism | Uncertain significance (Jun 14, 2016) | ||
6-10873278-G-A | Familial hypoparathyroidism | Uncertain significance (Jan 13, 2018) | ||
6-10873346-A-G | Familial hypoparathyroidism | Uncertain significance (Jan 13, 2018) | ||
6-10873352-T-A | Familial hypoparathyroidism | Likely benign (Jan 13, 2018) | ||
6-10873356-G-A | Familial hypoparathyroidism | Uncertain significance (Apr 27, 2017) | ||
6-10873361-G-A | Familial hypoparathyroidism | Benign (Jan 13, 2018) | ||
6-10873365-A-T | Familial hypoparathyroidism | Uncertain significance (Jan 12, 2018) | ||
6-10873384-A-G | Familial hypoparathyroidism | Uncertain significance (Jan 13, 2018) | ||
6-10873388-T-C | Familial hypoparathyroidism | Uncertain significance (Jan 12, 2018) | ||
6-10873407-T-C | Familial hypoparathyroidism | Uncertain significance (Jan 13, 2018) | ||
6-10873474-G-A | Familial hypoparathyroidism | Uncertain significance (Jan 13, 2018) | ||
6-10873474-G-T | Familial hypoparathyroidism | Benign (Jan 13, 2018) | ||
6-10873778-A-T | Familial hypoparathyroidism | Uncertain significance (Jan 13, 2018) | ||
6-10873945-C-T | Familial hypoparathyroidism | Uncertain significance (Jan 13, 2018) | ||
6-10874012-T-C | Likely pathogenic (Jan 18, 2016) | |||
6-10874012-T-G | Familial hypoparathyroidism • Hyperparathyroidism 4;Hypoparathyroidism, familial isolated, 2 | Uncertain significance (Nov 12, 2021) | ||
6-10874028-A-G | Likely benign (Dec 05, 2022) | |||
6-10874032-A-G | Inborn genetic diseases | Uncertain significance (Oct 27, 2022) | ||
6-10874054-C-A | Inborn genetic diseases | Uncertain significance (Aug 23, 2021) | ||
6-10874085-A-T | Familial hypoparathyroidism | Uncertain significance (Jan 12, 2018) | ||
6-10874107-GA-G | Uncertain significance (Mar 20, 2022) | |||
6-10874113-ACTGG-A | Uncertain significance (Jun 24, 2022) | |||
6-10874115-TG-T | Hypoparathyroidism, familial isolated, 2 | Pathogenic (Apr 30, 2021) | ||
6-10874118-C-G | Hyperparathyroidism 4 | Uncertain significance (Jul 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GCM2 | protein_coding | protein_coding | ENST00000379491 | 5 | 8719 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000911 | 0.987 | 125730 | 0 | 17 | 125747 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.676 | 246 | 278 | 0.886 | 0.0000159 | 3330 |
Missense in Polyphen | 57 | 80.814 | 0.70532 | 925 | ||
Synonymous | 0.345 | 103 | 108 | 0.958 | 0.00000676 | 986 |
Loss of Function | 2.21 | 8 | 18.1 | 0.441 | 0.00000103 | 201 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000528 | 0.0000527 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor that binds specific sequences on gene promoters and activate their transcription. Through the regulation of gene transcription, may play a role in parathyroid gland development. {ECO:0000269|PubMed:20190276, ECO:0000269|PubMed:27745835, ECO:0000269|PubMed:9928992}.;
- Disease
- DISEASE: Hypoparathyroidism, familial isolated (FIH) [MIM:146200]: A disorder characterized by hypocalcemia and hyperphosphatemia due to inadequate secretion of parathyroid hormone. Clinical features include seizures, tetany and cramps. {ECO:0000269|PubMed:15728199, ECO:0000269|PubMed:15863676, ECO:0000269|PubMed:20190276, ECO:0000269|PubMed:20463099, ECO:0000269|PubMed:23155703, ECO:0000269|Ref.3}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hyperparathyroidism 4 (HRPT4) [MIM:617343]: A form of familial primary hyperparathyroidism, an hypercalcemic disorder caused by inappropriate oversecretion of parathyroid hormone due to parathyroid hyperplasia or neoplasms. Clinical features include hypercalcemia, phosphaturia, and increased bone resorption. HRPT4 inheritance is autosomal dominant. {ECO:0000269|PubMed:27745835}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.589
- rvis_EVS
- 1.16
- rvis_percentile_EVS
- 92.59
Haploinsufficiency Scores
- pHI
- 0.269
- hipred
- N
- hipred_score
- 0.223
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gcm2
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- gcm2
- Affected structure
- neuromast hair cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- transcription by RNA polymerase II;cellular calcium ion homeostasis;multicellular organism development;cellular phosphate ion homeostasis;positive regulation of transcription by RNA polymerase II;parathyroid gland development
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;sequence-specific DNA binding;metal ion binding